Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.440
+0.010 (0.29%)
At close: Aug 18, 2026, 4:00 PM EDT
3.316
-0.124 (-3.61%)
After-hours: Aug 18, 2026, 7:56 PM EDT

NRx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.391.23----
Revenue Growth
------
Cost of Revenue
1.810.51----
Gross Profit
1.580.72----
Selling, General & Admin
15.9313.0613.514.2227.3174.94
Research & Development
5.413.786.213.3717.0320.26
Other Operating Expenses
------0.77
Operating Expenses
21.5516.9119.727.5944.3494.43
Operating Income
-19.96-16.19-19.7-27.59-44.34-94.43
Interest Expense
-1.14-0.67-0.23-0.12--0.02
Interest & Investment Income
0.020.010.040.490.25-
Other Non Operating Income (Expenses)
-5.02-7.77-3.780.020.261.69
EBT Excluding Unusual Items
-26.1-24.61-23.67-27.19-43.83-92.76
Gain (Loss) on Sale of Investments
-0.04-0.04----
Other Unusual Items
2.66-3.98-1.45-2.964.08-0.31
Pretax Income
-23.48-28.62-25.13-30.15-39.75-93.06
Net Income
-23.48-28.62-25.13-30.15-39.75-93.06
Preferred Dividends & Other Adjustments
---0.01--
Net Income to Common
-23.48-28.62-25.13-30.16-39.75-93.06
Net Income Growth
------
Shares Outstanding (Basic)
302111875
Shares Outstanding (Diluted)
302111875
Shares Change
110.42%101.06%40.50%15.20%40.17%36.90%
EPS (Basic)
-0.78-1.34-2.36-3.98-6.04-19.84
EPS (Diluted)
-0.78-1.34-2.36-3.98-6.04-74.40
EPS Growth
------
Free Cash Flow
-20.67-14.11-10.64-21.66-39.77-37.71
Free Cash Flow Per Share
-0.68-0.66-1.00-2.86-6.05-8.04
Gross Margin
46.64%58.78%----
Operating Margin
-588.21%-1321.47%----
Profit Margin
-691.81%-2336.49%----
Free Cash Flow Margin
-609.04%-1152.00%----
EBITDA
-19.76-16.12-19.7-27.58-44.33-94.43
D&A For EBITDA
0.20.070.010.0100
EBIT
-19.96-16.19-19.7-27.59-44.34-94.43
SEC Filings: 10-K · 10-Q